期刊文献+

炎症细胞因子与实验性2型糖尿病大鼠及肾脏改变 被引量:3

The changes of inflammatory factors and kidney injury in rat model of type 2 diabetes mellitus
下载PDF
导出
摘要 探讨炎性细胞因子与实验性2型糖尿病大鼠及肾脏病变。方法通过高糖高脂饮食结合小剂量链脲佐菌素的方法建立2型糖尿病大鼠动物模型。4、8周末测量大鼠空腹血糖(FBG)、血清胰岛素(FINs),18周末测量FBG、FINs、转化生长因子β1(TGF-β1)、瘦素(Leptin)、肿瘤坏死因子(TNF-α)水平并计算胰岛素抵抗指数(HOMA-IR)。用免疫组化、反转录多聚酶链反应(RT-PCR)检测TGF-β1在肾脏的表达情况。结果2型糖尿病大鼠血清TGF-β1、TNF-α、Leptin水平明显升高,同时肾脏的TGF-β1表达水平也升高,并伴有肾脏损害。结论实验性2型糖尿病大鼠存在炎性病变及肾脏损害。 Objective To investigate the changes of inflammatory factors and kidney injury in rat model of type 2 diabetes mellitus Methods The model of type 2 diabetes mellitus was set up by feeding high-glucose and highfat diet and by injecting STZ into peritoneal cavity of rat, At the end of 4 weeks and 8 weeks, the fasting blood glucose, the levels of fasting serum insulin were measured. At the end of 18 weeks the fasting blood glucose, the levels of fasting serum insulin, serum TGF-β1 ,TNF-α, Leptin in all the groups were measured. Moreover, immunohistochemistry and reverse transcription polymerase chain reaction(RT-PCR) was used to examine the pathological change of kidney and expression of TGF-β1 . Results The levels of TGF-1 ,TNF-α, Leptin in the kidney of the rats of type 2 diabetes mellitus obviously increased. The expressive levels of TGF-α in the kidney also increased. Conclusions There are inflammatory injuries in the kidney of rat model of type 2 diabetes mellitus.
出处 《河北医药》 CAS 2007年第2期99-101,共3页 Hebei Medical Journal
关键词 2型糖尿病 胰岛素抵抗 炎症 转化生长因子Β1 瘦素 肿瘤坏死因子-Α type 2 diabetes mellitus insulin resistance inflammation transforming growth factor β1 leptin tumor necrosis factor-alpha
  • 相关文献

参考文献14

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254
  • 2Haffner SM,Gonzalez C,Miettinen H,et al.A prospective analysis of the Homa model.The Mexico city diabetes study.Diabetes Care,1996,19:1138-1141.
  • 3程桦.肥胖、代谢综合征与炎症[J].国外医学(内分泌学分册),2004,24(3):151-153. 被引量:20
  • 4Marchesini G,Brizi M,Morselli Labate AM,et al.Association of nonalcoholic fatty liver disease with insulin resistance.Am J Med,1999,107:450-455.
  • 5Ito H,Ohshima A,Tsuzuki M,et al.Association of serum tumor necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women.Clin Exp Pharmacol Physiol,2001,28:188-192.
  • 6Wauters M,Considine RV,Yudkin JS,et al.Leptin levels in type 2 diabetes:associations with measures of insulin resistance and insulin secretion.Horm Metab Res,2003,35:92-96.
  • 7田成功,邵加庆,于镔.瘦素:胰岛素抵抗的独立危险因素?[J].中华内分泌代谢杂志,2002,18(3):184-187. 被引量:42
  • 8张国英,刘君.2型糖尿病患者血浆瘦素测定的临床意义[J].河北医药,2003,25(5):344-345. 被引量:3
  • 9彭立人.糖尿病肾病[J].中国全科医学,2006,9(2):91-93. 被引量:24
  • 10Mofiwaki Y,Yamamoto T,Shibutani Y,et al.Elevated levels of interleukin18and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus:relationship with diabetic nephropathy.Metabolism,2003,52:605-608.

二级参考文献53

  • 1曾赤佳,孟霞,胡河.糖尿病肾病患者血管内皮生长因子及血管紧张素Ⅱ含量分析[J].中国基层医药,2004,11(11):1294-1295. 被引量:7
  • 2周建辉,陈香美,谢院生,李建军,吴杰,蔡广研.糖尿病肾病与非糖尿病性肾脏疾病的对比分析及其诊断概率回归方程的建立[J].中华肾脏病杂志,2005,21(4):182-185. 被引量:25
  • 3Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients [ J ]. Diabetes Metabol Rev, 1988, 4:453-483.
  • 4American Diabetes Association. Clinical practice recommendations 2001[J]. Diabetes Care, 2001, 24: (Suppl 1) : 1 -33.
  • 5American Diabetes Association. Diabetic nephropathy [ J ]. Diabetes Care, 2002, 25 (Suppl 1): 85-89.
  • 6Karin JD, Zemin C, Alison J. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy [J]. Kidney Int, 1999,56 (Suppl 71): 31.
  • 7Park YS, Gudarro C, Kim Y, et al. Lovasatin reduces gomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephritic rats [J]. Am J Kidney Dis, 1998, 31:190.
  • 8Allison AE. Intemtitial fibrosis in hypereholesterole mic rats: role of oxidation, matrix synthesis, and proteolytic cascades [ J]. Kidney Int, 1998, 53: 1182.
  • 9Mitsuhiro F, Reiji T, Makiko Y, et al. Troglitazone ( CS - 045 ) ameliorates albuminuria in streptozotocin - induced diabetic rats [ J ].Metabolism, 1997, 46 (9): 98.
  • 10Nakamara T, Ushiyama C, Osada S, et al. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria [J]. Metabolism, 2001, 50 (10) : 1193.

共引文献640

同被引文献19

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254
  • 2李玮,张俊,乔燕舞,夏琳,傅莹.高浓度胺碘酮静脉泵入与静脉炎关系的临床研究[J].心血管康复医学杂志,2004,13(6):594-595. 被引量:163
  • 3朱大龙.炎症与2型糖尿病[J].中国糖尿病杂志,2006,14(1):73-74. 被引量:58
  • 4Erbagci AB, Tarakcioglu M, Coskun Y, et al. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem, 2001,34: 645-650.
  • 5Pradhan AD, Manson JE, Rafai N, et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286: 327-334.
  • 6Ziccardip P, Nappo F, Giugliano G, et al. Reduction of inflam- matory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year [ J ]. Circulation, 2002, 105 (7) : 804 - 809.
  • 7Esposito K, Ponfillo A, Dipalo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial [J]. JAMA, 2003, 289(14) : 1799 - 1804.
  • 8Van Exel E, Gussekloo J, de Craen A J, et al. Low production capacity of interleukin-lO associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study [ J ]. Diabetes, 2002, 51(4) : 1088 - 1092.
  • 9Anders HJ, Vielhauer V, SchlOndorff D. Chemokines and che- mokine receptors are involved in the resolution or progression of renal disease [J]. Kid Int, 2003, 63:401 -415.
  • 10Therous P, Lidon RM. Unstable angina: pathogenesis, diagno- sis, and treatment. Curt Probl Cardiol[ J]. 1993,18 : 157 - 181.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部